Stockscreener 앱 받기
2.18
28.24%
0.48
Traws Pharma Inc 주식(TRAW)의 최신 뉴스
Traws Pharma Soars As Hantavirus Antiviral Plan Sparks Rally - timothysykes.com
Traws Pharma (NASDAQ: TRAW) registers 35.9M resale shares - Stock Titan
Traws Pharma to Advance Potential Hantavirus Treatment Clinical Candidates - Contract Pharma
Traws Pharma Stock Jumps As Biotech Targets Hantavirus After Cruise Ship Deaths - TechStock²
Traws Pops on Hantavirus Research - Baystreet.ca
Traws Pharma Expands Antiviral Program to Target Hantavirus Infections; Shares Up Pre-Bell - Moomoo
Traws Pharma Gains After Hantavirus Drug Development Update Amid Cruise Ship Outbreak - Benzinga
TRAW Stock Jumps As Traders Zero In On Momentum And Cash Runway - StocksToTrade
TRAW Stock Pops On Volatile Run As Traders Eye Breakout - timothysykes.com
Traws Pharma to Advance Clinical Candidates for Hantavirus Infections - geneonline.com
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Traws Pharma To Advance Potential Clinical Candidates For The Treatment Of Hantavirus Infections - TradingView
Traws Pharma to develop hantavirus treatment candidates By Investing.com - Investing.com Australia
Traws Pharma to develop hantavirus treatment candidates - Investing.com
Traws Pharma Advances Development of Clinical Candidates for Hantavirus Treatment - Quiver Quantitative
No approved hantavirus treatment; Traws plans drug push - Stock Titan
Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections - ChartMill
Number of shareholders of Traws Pharma, Inc. – NASDAQ:TRAW - TradingView
Newtown-based Traws Pharma shares full-year results, clinical progress - MSN
OrbiMed (NASDAQ: TRAW) details 11.9% Traws Pharma stake and warrants - Stock Titan
TRAW (Traws Pharma) delivers stunning Q4 2025 EPS beat, shares rise 1.34% on upbeat investor reception.High Interest Stocks - newser.com
Traws Pharma posts 150.5% EPS surprise turning profitable vs loss estimatesElite Trading Signals - Newser
Traws Pharma, Inc. 2025 Executive Compensation, Governance, and Board of Directors Overview - Minichart
Traws Pharma (NASDAQ: TRAW) 10-K/A details board, pay and ownership - Stock Titan
Insider Stock Purchases: April 29, 2026 - Quiver Quantitative
Traws Pharma Stock (TRAW) Opinions on Insider Purchase - Quiver Quantitative
Tuesday’s insider activity: Major sells at Avis Budget, buys at Abbott By Investing.com - Investing.com South Africa
Tuesday’s insider activity: Major sells at Avis Budget, buys at Abbott - Investing.com UK
TRAW Traws Pharma delivers massive Q4 2025 earnings beat, shares gain 7.44 percent on positive investor sentiment.Management Guidance - Newser
TRAW | Traws Pharma, Inc. Common Insider Trading - Quiver Quantitative
OrbiMed acquires $998,207 in Traws Pharma common stock By Investing.com - Investing.com Australia
OrbiMed acquires $998,207 in Traws Pharma common stock - Investing.com
OrbiMed (NASDAQ: TRAW) adds Traw Pharma stock and warrant stake - Stock Titan
TRAW - Finviz
Traws Pharma (TRAW) price target decreased by 24.14% to 5.61 - MSN
Traws Pharma, Inc. (TRAW) forms 'hammer chart pattern': Time for bottom fishing? - MSN
Newtown-Based Traws Pharma Shares Full-Year Results, Clinical Progress - BUCKSCO.Today
Traws Pharma Inc. notches 43.1% EPS beat on narrower lossCommunity Breakout Alerts - Cổng thông tin điện tử tỉnh Lào Cai
Traws Pharma Q4 2025 Earnings Call Transcript - MarketBeat
Traws Pharma (TRAW) Sector Trends | Traws Pharma Inc. notches 43.1% EPS beat on narrower lossOptions Activity - Cổng thông tin điện tử Tỉnh Sơn La
Traws Pharma Reports 2025 Results, Secures Up to $60M Financing - MyChesCo
Traws Pharma (TRAW) Stock Breakdown Level (Smart Money Flows) 2026-04-20Viral Momentum Stocks - UBND thành phố Hải Phòng
Traws Pharma Secures Up to $60 Million in Private Placement Financing - Global Legal Chronicle
Traws Pharma, Inc. (TRAW) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? - Yahoo Finance
Cash per share of Traws Pharma, Inc. – MUN:0T20 - TradingView
Is Traws Pharma (TRAW) a Possible Value Trap After FY2025 Result - GuruFocus
TRAW Stock Chart | TRAWS PHARMA INC (NASDAQ:TRAW) - ChartMill
Traws outlines $60M financing while targeting flu challenge study this summer and runway into Q1 2027 - MSN
Earnings call transcript: Traws Pharma Q4 2025 shows strategic shift boosts revenue By Investing.com - Investing.com South Africa
Earnings call transcript: Traws Pharma Q4 2025 shows strategic shift boosts revenue - Investing.com
Traws Pharma, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Traws Pharma (TRAW) Secures $60 Million Financing for Influenza Research - GuruFocus
Traws Pharma Announces Up to $60 Million Private Placement Financing - Sahm
Traws Pharma Inc (TRAW) Q4 2025 Earnings Call Highlights: A Turnaround Year with Significant ... By GuruFocus - Investing.com Canada
11.97%
3.48%
자본화:
|
볼륨(24시간):